HCV - Insulin Resistance / Diabetes

Insulin-sensitizing Agent Pioglitazone (Actos) Did Not Improve Response to Re-treatment with Pegylated Interferon plus Ribavirin - 8/29/2008

Obesity and Diabetes Are Linked to Increased Risk of Liver Cancer - 7/18/08

Insulin Resistance and Diabetes Increase the Risk of Liver Fibrosis and Hepatocellular Carcinoma in People with Chronic Hepatitis C - 7/04/08

Sustained Response to Interferon-based Therapy Reduces the Likelihood of Type 2 Diabetes - 6/24/08

Insulin Resistance and Diabetes Increase the Risk of Liver Fibrosis and Hepatocellular Carcinoma in People with Chronic Hepatitis C - 6/24/08

Sustained Response to Interferon-based Therapy Reduces the Likelihood of Type 2 Diabetes - 6/24/08

Insulin Resistance is a Risk Factor for Liver Fibrosis Even without Steatosis - 2/29/08

Insulin Resistance Linked to Lower Treatment Response in Genotype 2/3 Patients - 2/01/08

Community-based Study in Taiwan Provides More Evidence of Link between Hepatitis C and Type 2 Diabetes    - 8/17/07

Insulin Resistance and Liver Injury in Hepatitis C Patients Are Not Associated with Virus-Specific Changes in Adipocytokines    - 7/17/07

Hepatitis C Viremia, but Not Hepatitis B, Is Associated with Increased Diabetes Risk    - 7/17/07

Diabetes Treatment May Improve Response to Pegylated Interferon/Ribavirin, and HCV Eradication in Turn May Reduce Insulin Resistance   - 6/19/07

Diabetes is Associated with Hepatic Encephalopathy in Patients with HCV-Related Cirrhosis- 8/18/06

More Evidence that Hepatitis C Virus Infection is Associated with Insulin Resistance   2/23/07

HCV Clearance Improves Insulin Resistance 2/06/07

Impact and Management of Insulin Resistance in Patients with Hepatitis C  12/12/06